Prostatype Genomics AB (publ) announced executive changes. The company announced election of Henrik Nilsson as new member of the board and Karlheinz Schmelig was not available for re-election.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0416 SEK | +7.22% | +1.96% | -56.21% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.21% | 3.52M | |
-16.55% | 8.43B | |
+39.66% | 3.62B | |
-38.71% | 2.61B | |
-8.06% | 2.48B | |
-7.96% | 2.34B | |
-12.52% | 1.94B | |
-19.51% | 1.56B | |
-40.78% | 1.26B | |
+8.32% | 1.1B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Announces Executive Changes